Vident Investment Advisory’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Vident Investment Advisory’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-355,459	Closed	-$28.4K	–	1333
2022 Q4	$28.4K	Sell	355,459 -292,566	-45%	-$134K	﹤0.01%	1166
2022 Q3	$843K	Buy	648,025 +628,716	+3,256%	+$1.34M	0.03%	639
2022 Q2	$29K	Buy	19,309 +4,828	+33%	+$22.2K	﹤0.01%	1254
2022 Q1	$119K	Buy	+14,481	New	+$128K	﹤0.01%	1227

Other funds holding CORZ

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

CWC

Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return

BWP

BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Vident Investment Advisory's CORZ Position: Q1 2023 in Review

Vident Investment Advisory sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 355,459 shares — an estimated $28.4K sold.

Vident Investment Advisory first reported a position in CORZ in Q1 2022 and held it in 4 quarters. The position peaked at $843K in Q3 2022. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

Vident Investment Advisory reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Vident Investment Advisory sold 355,459 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $28.4K.
Vident Investment Advisory first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Vident Investment Advisory's Core Scientific, Inc. Common Stock position peaked at $843K in Q3 2022.
10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on Vident Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.